-
1
-
-
0035496220
-
The development of androgen-independent prostate cancer
-
Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1:34-45. (Pubitemid 33741879)
-
(2001)
Nature Reviews Cancer
, vol.1
, Issue.1
, pp. 34-45
-
-
Feldman, B.J.1
Feldman, D.2
-
2
-
-
67650874081
-
Cancer statistics, 2009
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
3
-
-
85003173512
-
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
-
DOI 10.1210/me.7.12.1541
-
Culig Z, Hobisch A, Cronauer MV, Cato AC, Hittmair A, Radmayr C, et al. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 1993;7:1541-50. (Pubitemid 24034236)
-
(1993)
Molecular Endocrinology
, vol.7
, Issue.12
, pp. 1541-1550
-
-
Culig, Z.1
Hobisch, A.2
Cronauer, M.V.3
Cato, A.C.B.4
Hittmair, A.5
Radmayr, C.6
Eberle, J.7
Bartsch, G.8
Klocker, H.9
-
4
-
-
0035361340
-
A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy
-
Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS, et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 2001;61:4315-9. (Pubitemid 32685750)
-
(2001)
Cancer Research
, vol.61
, Issue.11
, pp. 4315-4319
-
-
Gregory, C.W.1
He, B.2
Johnson, R.T.3
Ford, O.H.4
Mohler, J.L.5
French, F.S.6
Wilson, E.M.7
-
5
-
-
15644368237
-
Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer
-
Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997;57:314-9. (Pubitemid 27036612)
-
(1997)
Cancer Research
, vol.57
, Issue.2
, pp. 314-319
-
-
Koivisto, P.1
Kononen, J.2
Palmberg, C.3
Tammela, T.4
Hyytinen, E.5
Isola, J.6
Trapman, J.7
Cleutjens, K.8
Noordzij, A.9
Visakorpi, T.10
Kallioniemi, O.-P.11
-
6
-
-
0033022342
-
A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
-
DOI 10.1038/6495
-
Craft N, Shostak Y, Carey M, Sawyers CL. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999;5:280-5. (Pubitemid 29124362)
-
(1999)
Nature Medicine
, vol.5
, Issue.3
, pp. 280-285
-
-
Craft, N.1
Shostak, Y.2
Carey, M.3
Sawyers, C.L.4
-
7
-
-
1842429920
-
Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells
-
DOI 10.1038/sj.onc.1207304
-
Kim O, Jiang T, Xie Y, Guo Z, Chen H, Qiu Y. Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells. Oncogene 2004;23:1838-44. (Pubitemid 38445409)
-
(2004)
Oncogene
, vol.23
, Issue.10
, pp. 1838-1844
-
-
Kim, O.1
Jiang, T.2
Xie, Y.3
Guo, Z.4
Chen, H.5
Qiu, Y.6
-
8
-
-
16644387106
-
Prostate cancer 2004: Insights from national disease registries
-
Cooperberg MR, Park S, Carroll PR. Prostate cancer 2004: insights from national disease registries. Oncology 2004;18:1239-47.
-
(2004)
Oncology
, vol.18
, pp. 1239-1247
-
-
Cooperberg, M.R.1
Park, S.2
Carroll, P.R.3
-
9
-
-
9444261998
-
Chemotherapy for patients with hormone-refractory prostate cancer
-
DOI 10.1093/annonc/mdh445
-
Joly F, Tannock IF. Chemotherapy for patients with hormone-refractory prostate cancer. Ann Oncol 2004;15:1582-4. (Pubitemid 39562597)
-
(2004)
Annals of Oncology
, vol.15
, Issue.11
, pp. 1582-1584
-
-
Joly, F.1
Tannock, I.F.2
-
10
-
-
4744366279
-
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
-
DOI 10.1056/NEJMoa040720
-
Tannock IF, de WR, Berry WR, Horti J, Pluzanska A, Chi KN, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;351:1502-12. (Pubitemid 39315317)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.15
, pp. 1502-1512
-
-
Tannock, I.F.1
De Wit, R.2
Berry, W.R.3
Horti, J.4
Pluzanska, A.5
Chi, K.N.6
Oudard, S.7
Theodore, C.8
James, N.D.9
Turesson, I.10
Rosenthal, M.A.11
Eisenberger, M.A.12
-
11
-
-
36849061167
-
Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells
-
DOI 10.1016/j.canlet.2007.09.018, PII S0304383507004491
-
Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, Eudy JD, et al. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. Cancer Lett 2008;259:28-38. (Pubitemid 350235090)
-
(2008)
Cancer Letters
, vol.259
, Issue.1
, pp. 28-38
-
-
Singh, A.P.1
Bafna, S.2
Chaudhary, K.3
Venkatraman, G.4
Smith, L.5
Eudy, J.D.6
Johansson, S.L.7
Lin, M.-F.8
Batra, S.K.9
-
12
-
-
33846230600
-
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays
-
DOI 10.1038/sj.bjc.6603490, PII 6603490
-
Prowatke I, Devens F, Benner A, Grone EF, Mertens D, Grone HJ, et al. Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. Br J Cancer 2007;96:82-8. (Pubitemid 46094643)
-
(2007)
British Journal of Cancer
, vol.96
, Issue.1
, pp. 82-88
-
-
Prowatke, I.1
Devens, F.2
Benner, A.3
Grone, E.F.4
Mertens, D.5
Grone, H.-J.6
Lichter, P.7
Joos, S.8
-
13
-
-
0023676445
-
Tissue-specific expression of mRNAs encoding alpha- and beta-catalytic subunits of protein phosphatase 2A
-
Khew-Goodall Y, Hemmings BA. Tissue-specific expression of mRNAs encoding alpha- and beta-catalytic subunits of protein phosphatase 2A. FEBS Lett 1988;238:265-8.
-
(1988)
FEBS Lett
, vol.238
, pp. 265-268
-
-
Khew-Goodall, Y.1
Hemmings, B.A.2
-
14
-
-
0035252894
-
Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling
-
DOI 10.1042/0264-6021:3530417
-
Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001;353:417-39. (Pubitemid 32158309)
-
(2001)
Biochemical Journal
, vol.353
, Issue.3
, pp. 417-439
-
-
Janssens, V.1
Goris, J.2
-
15
-
-
29044443481
-
P38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-α induced endothelial apoptosis
-
DOI 10.1016/j.cellsig.2005.05.023, PII S0898656805001324
-
Grethe S, Porn-Ares MI. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis. Cell Signal 2006;18:531-40. (Pubitemid 41790373)
-
(2006)
Cellular Signalling
, vol.18
, Issue.4
, pp. 531-540
-
-
Grethe, S.1
Porn-Ares, M.I.2
-
16
-
-
0030769625
-
Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-κB activation
-
DOI 10.1093/emboj/16.18.5662
-
Sontag E, Sontag JM, Garcia A. Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. EMBO J 1997;16:5662-71. (Pubitemid 27399858)
-
(1997)
EMBO Journal
, vol.16
, Issue.18
, pp. 5662-5671
-
-
Sontag, E.1
Sontag, J.-M.2
Garcia, A.3
-
17
-
-
27744512550
-
Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt
-
DOI 10.1074/jbc.M506986200
-
Van Kanegan MJ, Adams DG, Wadzinski BE, Strack S. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J Biol Chem 2005;280:36029-36. (Pubitemid 41633873)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.43
, pp. 36029-36036
-
-
Van Kanegan, M.J.1
Adams, D.G.2
Wadzinski, B.E.3
Strack, S.4
-
18
-
-
0032514680
-
Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Cα
-
DOI 10.1073/pnas.95.21.12370
-
Gotz J, Probst A, Ehler E, Hemmings B, Kues W. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc Natl Acad Sci U S A 1998;95:12370-5. (Pubitemid 28483772)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.21
, pp. 12370-12375
-
-
Gotz, J.1
Probst, A.2
Ehler, E.3
Hemmings, B.4
Kues, W.5
-
19
-
-
0037007096
-
Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits
-
DOI 10.1073/pnas.072071699
-
Silverstein AM, Barrow CA, Davis AJ, Mumby MC. Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits. Proc Natl Acad Sci U S A 2002;99:4221-6. (Pubitemid 34285967)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.7
, pp. 4221-4226
-
-
Silverstein, A.M.1
Barrow, C.A.2
Davis, A.J.3
Mumby, M.C.4
-
20
-
-
9144223779
-
Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival
-
DOI 10.1074/jbc.M408015200
-
Strack S, Cribbs JT, Gomez L. Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival. J Biol Chem 2004;279:47732-9. (Pubitemid 39540921)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.46
, pp. 47732-47739
-
-
Strack, S.1
Cribbs, J.T.2
Gomez, L.3
-
21
-
-
28444483130
-
γ-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair
-
DOI 10.1016/j.molcel.2005.10.003, PII S1097276505016734
-
Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J. gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell 2005;20:801-9. (Pubitemid 41740701)
-
(2005)
Molecular Cell
, vol.20
, Issue.5
, pp. 801-809
-
-
Chowdhury, D.1
Keogh, M.-C.2
Ishii, H.3
Peterson, C.L.4
Buratowski, S.5
Lieberman, J.6
-
22
-
-
34248393912
-
Wnt/β-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency
-
DOI 10.1073/pnas.0701331104
-
Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, Kahn M. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A 2007;104:5668-73. (Pubitemid 47175738)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.13
, pp. 5668-5673
-
-
Miyabayashi, T.1
Teo, J.-L.2
Yamamoto, M.3
McMillan, M.4
Nguyen, C.5
Kahn, M.6
-
23
-
-
78650194206
-
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: A novel target for therapy
-
Singh S, Srivastava SK, Bhardwaj A, Owen LB, Singh AP. CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. Br J Cancer 2010;103:1671-9.
-
(2010)
Br J Cancer
, vol.103
, pp. 1671-1679
-
-
Singh, S.1
Srivastava, S.K.2
Bhardwaj, A.3
Owen, L.B.4
Singh, A.P.5
-
24
-
-
0041828714
-
C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells
-
DOI 10.1002/pros.10275
-
Eto M, Bennouna J, Hunter OC, Hershberger PA, Kanto T, Johnson CS, et al. C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells. Prostate 2003;57:66-79. (Pubitemid 37070151)
-
(2003)
Prostate
, vol.57
, Issue.1
, pp. 66-79
-
-
Eto, M.1
Bennouna, J.2
Hunter, O.C.3
Hershberger, P.A.4
Kanto, T.5
Johnson, C.S.6
Lotze, M.T.7
Amoscato, A.A.8
-
25
-
-
0036784080
-
Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis
-
Kazi A, Smith DM, Zhong Q, Dou QP. Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis. Mol Pharmacol 2002;62:765-71.
-
(2002)
Mol Pharmacol
, vol.62
, pp. 765-771
-
-
Kazi, A.1
Smith, D.M.2
Zhong, Q.3
Dou, Q.P.4
-
26
-
-
0032493489
-
1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells
-
DOI 10.1074/jbc.273.32.20213
-
Knudsen KE, Arden KC, Cavenee WK. Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells. J Biol Chem 1998;273:20213-22. (Pubitemid 28377582)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.32
, pp. 20213-20222
-
-
Knudsen, K.E.1
Arden, K.C.2
Cavenee, W.K.3
-
27
-
-
0033119571
-
Antiapoptotic signaling in LNCaP prostate cancer cells: A survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B
-
Carson JP, Kulik G, Weber MJ. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B. Cancer Res 1999;59:1449-53. (Pubitemid 29160109)
-
(1999)
Cancer Research
, vol.59
, Issue.7
, pp. 1449-1453
-
-
Carson, J.P.1
Kulik, G.2
Weber, M.J.3
-
28
-
-
0034749615
-
Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state
-
DOI 10.1210/en.142.11.4795
-
Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 2001;142:4795-805. (Pubitemid 33022355)
-
(2001)
Endocrinology
, vol.142
, Issue.11
, pp. 4795-4805
-
-
Murillo, H.1
Huang, H.2
Schmidt, L.J.3
Smith, D.I.4
Tindall, D.J.5
-
29
-
-
0037636375
-
TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP
-
Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Syrbu SI, Cohen MB. TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP. Cancer Biol Ther 2002;1:631-7.
-
(2002)
Cancer Biol Ther
, vol.1
, pp. 631-637
-
-
Rokhlin, O.W.1
Taghiyev, A.F.2
Guseva, N.V.3
Glover, R.A.4
Syrbu, S.I.5
Cohen, M.B.6
-
30
-
-
2442528552
-
Androgen Receptor Mediates Non-genomic Activation of Phosphatidylinositol 3-OH Kinase in Androgen-sensitive Epithelial Cells
-
DOI 10.1074/jbc.M306143200
-
Baron S, Manin M, Beaudoin C, Leotoing L, Communal Y, Veyssiere G, et al. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem 2004;279:14579-86. (Pubitemid 38618845)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.15
, pp. 14579-14586
-
-
Baron, S.1
Manin, M.2
Beaudoin, C.3
Leotoing, L.4
Communal, Y.5
Veyssiere, G.6
Morel, L.7
-
31
-
-
67049155478
-
Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: Roles of ERK/MAP kinase
-
Shigemura K, Isotani S, Wang R, Fujisawa M, Gotoh A, Marshall FF, et al. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase. Prostate 2009;69:949-55.
-
(2009)
Prostate
, vol.69
, pp. 949-955
-
-
Shigemura, K.1
Isotani, S.2
Wang, R.3
Fujisawa, M.4
Gotoh, A.5
Marshall, F.F.6
-
32
-
-
0029073053
-
The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide
-
Law B, Rossie S. The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide. J Biol Chem 1995;270:12808-13.
-
(1995)
J Biol Chem
, vol.270
, pp. 12808-12813
-
-
Law, B.1
Rossie, S.2
-
33
-
-
0033575320
-
Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A
-
Ruvolo PP, Deng X, Ito T, Carr BK, May WS. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 1999;274:20296-300.
-
(1999)
J Biol Chem
, vol.274
, pp. 20296-20300
-
-
Ruvolo, P.P.1
Deng, X.2
Ito, T.3
Carr, B.K.4
May, W.S.5
-
34
-
-
77955510774
-
Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer
-
Corcoran NM, Hovens CM, Michael M, Rosenthal MA, Costello AJ. Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer. Br J Cancer 2010;103:462-8.
-
(2010)
Br J Cancer
, vol.103
, pp. 462-468
-
-
Corcoran, N.M.1
Hovens, C.M.2
Michael, M.3
Rosenthal, M.A.4
Costello, A.J.5
-
35
-
-
0033520806
-
Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
-
Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW, et al. Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J Natl Cancer Inst 1999;91:1869-76.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1869-1876
-
-
Agus, D.B.1
Cordon-Cardo, C.2
Fox, W.3
Drobnjak, M.4
Koff, A.5
Golde, D.W.6
-
36
-
-
0027093255
-
Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
-
McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992;52:6940-4. (Pubitemid 23006303)
-
(1992)
Cancer Research
, vol.52
, Issue.24
, pp. 6940-6944
-
-
McDonnell, T.J.1
Troncoso, P.2
Brisbay, S.M.3
Logothetis, C.4
Chung, L.W.K.5
Hsieh, J.-T.6
Tu, S.-M.7
Campbell, M.L.8
-
37
-
-
33846968797
-
Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis
-
Schmitz M, Grignard G, Margue C, Dippel W, Capesius C, Mossong J, et al. Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis. Int J Cancer 2007;120:1284-92.
-
(2007)
Int J Cancer
, vol.120
, pp. 1284-1292
-
-
Schmitz, M.1
Grignard, G.2
Margue, C.3
Dippel, W.4
Capesius, C.5
Mossong, J.6
-
38
-
-
0034637524
-
Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27(Kip1) expression
-
DOI 10.1074/jbc.M003145200
-
Graff JR, Konicek BW, McNulty AM, Wang Z, Houck K, Allen S, et al. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J Biol Chem 2000;275:24500-5. (Pubitemid 30626543)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.32
, pp. 24500-24505
-
-
Graff, J.R.1
Konicek, B.W.2
McNulty, A.M.3
Wang, Z.4
Houck, K.5
Allen, S.6
Paul, J.D.7
Hbaiu, A.8
Goode, R.G.9
Sandusky, G.E.10
Vessella, R.L.11
Neubauer, B.L.12
-
39
-
-
0036554734
-
Immunohistochemical demonstration of phospho-Akt in high gleason grade prostate cancer
-
Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, et al. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res 2002;8:1168-71. (Pubitemid 35177371)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.4
, pp. 1168-1171
-
-
Malik, S.N.1
Brattain, M.2
Ghosh, P.M.3
Troyer, D.A.4
Prihoda, T.5
Bedolla, R.6
Kreisberg, J.I.7
-
40
-
-
77958168429
-
Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells
-
Kim SW, Kim HJ, Chun YJ, Kim MY. Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells. J Toxicol Environ Health A 2010;73:1465-76.
-
(2010)
J Toxicol Environ Health A
, vol.73
, pp. 1465-1476
-
-
Kim, S.W.1
Kim, H.J.2
Chun, Y.J.3
Kim, M.Y.4
-
41
-
-
34047141137
-
Conditional Akt activation promotes androgen-independent progression of prostate cancer
-
DOI 10.1093/carcin/bgl193
-
Li B, Sun A, Youn H, Hong Y, Terranova PF, Thrasher JB, et al. Conditional Akt activation promotes androgen-independent progression of prostate cancer. Carcinogenesis 2007;28:572-83. (Pubitemid 46523353)
-
(2007)
Carcinogenesis
, vol.28
, Issue.3
, pp. 572-583
-
-
Li, B.1
Sun, A.2
Youn, H.3
Hong, Y.4
Terranova, P.F.5
Thrasher, J.B.6
Xu, P.7
Spencer, D.8
-
42
-
-
33749254070
-
Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
-
DOI 10.1073/pnas.0606836103
-
Gao H, Ouyang X, Banach-Petrosky WA, Gerald WL, Shen MM, Abate-Shen C. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci U S A 2006;103:14477-82. (Pubitemid 44484775)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.39
, pp. 14477-14482
-
-
Gao, H.1
Ouyang, X.2
Banach-Petrosky, W.A.3
Gerald, W.L.4
Shen, M.M.5
Abate-Shen, C.6
-
43
-
-
0028113415
-
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
-
Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, et al. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994;54:5474-8.
-
(1994)
Cancer Res
, vol.54
, pp. 5474-5478
-
-
Culig, Z.1
Hobisch, A.2
Cronauer, M.V.3
Radmayr, C.4
Trapman, J.5
Hittmair, A.6
-
44
-
-
0033545848
-
From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
-
DOI 10.1073/pnas.96.10.5458
-
Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, Chang C. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci U S A 1999;96:5458-63. (Pubitemid 29234639)
-
(1999)
Proceedings of the National Academy of Sciences of the United States of America
, vol.96
, Issue.10
, pp. 5458-5463
-
-
Yeh, S.1
Lin, H.-K.2
Kang, H.-Y.3
Thin, T.H.4
Lin, M.-F.5
Chang, C.6
-
45
-
-
0035912833
-
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor
-
DOI 10.1073/pnas.121173298
-
Lin HK, Yeh S, Kang HY, Chang C. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc Natl Acad Sci U S A 2001;98:7200-5. (Pubitemid 32567926)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.13
, pp. 7200-7205
-
-
Lin, H.-K.1
Yeh, S.2
Kang, H.-Y.3
Chang, C.4
-
46
-
-
0034671668
-
HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway
-
Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH, et al. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res 2000;60:6841-5. (Pubitemid 32059149)
-
(2000)
Cancer Research
, vol.60
, Issue.24
, pp. 6841-6845
-
-
Wen, Y.1
Hu, M.C.-T.2
Makino, K.3
Spohn, B.4
Bartholomeusz, G.5
Yan, D.-H.6
Hung, M.-C.7
-
47
-
-
33646739524
-
Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor
-
Xin L, Teitell MA, Lawson DA, Kwon A, Mellinghoff IK, Witte ON. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc Natl Acad Sci U S A 2006;103:7789-94.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 7789-7794
-
-
Xin, L.1
Teitell, M.A.2
Lawson, D.A.3
Kwon, A.4
Mellinghoff, I.K.5
Witte, O.N.6
-
48
-
-
70350036005
-
Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1
-
Chen S, Kesler CT, Paschal BM, Balk SP. Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1. J Biol Chem 2009;284:25576-84.
-
(2009)
J Biol Chem
, vol.284
, pp. 25576-25584
-
-
Chen, S.1
Kesler, C.T.2
Paschal, B.M.3
Balk, S.P.4
|